KDM7A and head and neck squamous cell carcinoma: To further validate our results in patient samples showing that miR-451a and KDM7A are important contributors to cetuximab resistance and to explore the applicability of these two genes in cetuximab treatment and prognostics, we collected 87 patients with confirmed HNSCC who received cetuximab treatment from our centre.